1Endo T, Minami M, Kitamura N, et al, Effects of Various 5 - HT3 receptor antagonists, granisetron, ondansetron, Ramosetron and azasetron on serotonin(5 -HT) release from the ferret isolated ileum [J]. Res Comnun Mol Pathol Pharmacol, 1999,104 (2) : 145 - 155.
3Tan M.Graniseron:new insights into its use for the treatment of chemotherapy induced nausea and womiting[J].Expert opin pharmacother,2003,4(9):1563.
4Stoltz R,Parisi S,Shah A,et al.Pharmacokinetics,metabolism and excretion of intravenous -palonooetron in healthy human volunteers[J].Biopharm Drug Dispos,2004,25(8):329.
5Aapro E,Selak M,Lichinitser D,et al.Palonosetron (PALO)is more effective than ondansetron (OND) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients recerving moderately emetogenic chemotherapy (MEX):Results of a phase III trial[J].Proc Am Soc Clin Oncol,2003,22:726.
7Schwartzberg LS.Chemotherapy-induced nausea and vom- iting:clinician and patient perspectives[].J Support Oncol.2007
8Kris MG,Hesketh P J,Somerfield MR,et al.American Socie- ty of Clinical Oncology guideline for antiemetics in oncology: update 2006[].Journal of Clinical Oncology.2006
9American Society of Health-System Pharmacists.ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery[].American Journal of Health System Pharmacy.1999
10Gralla R,Lichinitser M,Vau Der Vegt S,et al.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:re- sults of a double-blind randomized phaseⅢtrial comparing single doses of palonosetron with ondansetron[].Annals of Oncology.2003
